Bioventus Signs Pfizer as Exclusive DUROLANE Distributor in Brazil

Bioventus received ANVISA approval to market DUROLANE® single-injection in Brazil to treat hip osteoarthritis.

Pfizer, Bioventus' choice of exclusive distribution partner, has >100 sales representatives throughout Brazil and will offer DUROLANE as part of a pain management portfolio alongside the NSAID CELEBRA®.

Bioventus entered into a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us